Results 161 to 170 of about 11,360 (208)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Biopharmaceutics and Drug Disposition, 2012
ABSTRACTLumefantrine has been reported to be mainly bio‐transformed by cytochrome P450 isozyme 3A4 to desbutyl‐lumefantrine (DLF) in human liver microsomes. Since CYP3A is expressed in a sex specific manner in rats, it could be expected that the pharmacokinetics of lumefantrine would be changed in male rats compared with those in female rats.
, Wahajuddin +2 more
exaly +3 more sources
ABSTRACTLumefantrine has been reported to be mainly bio‐transformed by cytochrome P450 isozyme 3A4 to desbutyl‐lumefantrine (DLF) in human liver microsomes. Since CYP3A is expressed in a sex specific manner in rats, it could be expected that the pharmacokinetics of lumefantrine would be changed in male rats compared with those in female rats.
, Wahajuddin +2 more
exaly +3 more sources
Artemether-Lumefantrine: An Option for Malaria
Annals of Pharmacotherapy, 2012Objective: To review the pharmacology, pharmacokinetics, safety, and efficacy of artemether-lumefantrine for the treatment of Plasmodium falciparum malaria. Data Sources: English-language articles indexed in PubMed (1947-November 2011)
Travis King
exaly +3 more sources
Xenobiotica, 2020
Lumefantrine (LFN) is a chiral antimalarial drug. Enantioselective in vitro attributes and absolute oral pharmacokinetics for (-)-LFN and (+)-LFN have been characterized in mice. No stereoselectivity was seen with either of the enantiomers when compared with rac-LFN in the executed in vitro studies (solubility, metabolic stability, protein binding ...
Bhavesh Babulal Gabani +6 more
openaire +2 more sources
Lumefantrine (LFN) is a chiral antimalarial drug. Enantioselective in vitro attributes and absolute oral pharmacokinetics for (-)-LFN and (+)-LFN have been characterized in mice. No stereoselectivity was seen with either of the enantiomers when compared with rac-LFN in the executed in vitro studies (solubility, metabolic stability, protein binding ...
Bhavesh Babulal Gabani +6 more
openaire +2 more sources

